532 related articles for article (PubMed ID: 9707454)
1. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
3. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction.
Löfdahl CG; Andersson L; Bondesson E; Carlsson LG; Friberg K; Hedner J; Hörnblad Y; Jemsby P; Källén A; Ullman A; Werner S; Svedmyr N
Eur Respir J; 1997 Nov; 10(11):2474-8. PubMed ID: 9426081
[TBL] [Abstract][Full Text] [Related]
4. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.
Broeders ME; Molema J; Hop WC; Folgering HT
Eur J Clin Pharmacol; 2005 Feb; 60(12):837-41. PubMed ID: 15625613
[TBL] [Abstract][Full Text] [Related]
5. Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler DPI.
Newhouse MT; Patel P; Parry-Billings M
Eur Respir J; 2003 May; 21(5):816-20. PubMed ID: 12765427
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the bronchodilatory effect of 50 and 100 microg salbutamol via Turbuhaler and 100 microg salbutamol via pressurized metered dose inhaler in children with stable asthma.
Razzouk H; dos Santos L; Giudicelli J; Queirós M; de Lurdes Chieira M; Castro A; Ramos C; Lindbladh C
Int J Pharm; 1999 Apr; 180(2):169-75. PubMed ID: 10370187
[TBL] [Abstract][Full Text] [Related]
7. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma.
Nana A; Youngchaiyud P; Maranetra N; Boe J; Löfdahl CG; Selroos O; Ståhl E
Respir Med; 1998 Feb; 92(2):167-72. PubMed ID: 9616507
[TBL] [Abstract][Full Text] [Related]
9. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
[TBL] [Abstract][Full Text] [Related]
10. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices.
Seppälä OR; Aalto E; Annila ; Hakonen T; Lukkari-Lax E; Jouhikainen T; Nieminen MM; Liipp K
Respir Med; 2001 Dec; 95(12):949-53. PubMed ID: 11778791
[TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
14. Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler.
Mellén A; Arvidsson P; Palmqvist M; Lötvall J
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1663-5. PubMed ID: 10228142
[TBL] [Abstract][Full Text] [Related]
15. Agreement between two methods for assessing bioequivalence of inhaled salbutamol.
Lavorini F; Geri P; Camiciottoli G; Pistolesi M; Fontana GA
Pulm Pharmacol Ther; 2008; 21(2):380-4. PubMed ID: 17997115
[TBL] [Abstract][Full Text] [Related]
16. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
[TBL] [Abstract][Full Text] [Related]
17. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
[TBL] [Abstract][Full Text] [Related]
18. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer.
Seppälä OP; Herrala J; Hedman J; Alanko K; Liipo K; Terho E; Pietinalho A; Nyholm JE; Nieminen MM
Respir Med; 1998 Mar; 92(3):578-83. PubMed ID: 9692126
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma.
Mallol J; Aguirre V; Rhem R; Rodriguez J; Dolovich M
Pediatr Pulmonol; 2001 Dec; 32(6):447-52. PubMed ID: 11747248
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
Bondesson E; Friberg K; Soliman S; Löfdahl CG
Respir Med; 1998 Feb; 92(2):325-30. PubMed ID: 9616533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]